Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$8,842,549
+$208,455 QoQ
Shares Held
46,633
+6.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#317
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Metis Global Partners, LLC holds $140,227,316 across 10 Drug Manufacturers - General names. AZN ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
43,943 | $52,706,556 | |
| 2 | JNJ |
Johnson & Johnson
|
93,168 | $23,661,876 | |
| 3 | ABBV |
AbbVie Inc.
|
82,938 | $20,870,518 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,719 | $13,199,391 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
46,633 | $8,842,549 | |
| 6 | AMGN |
Amgen Inc
|
17,289 | $6,260,692 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
43,024 | $5,435,652 | |
| 8 | PFE |
Pfizer Inc
|
181,310 | $4,365,944 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,842,549 | 46,633 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,634,094 | 43,779 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||